Mechanisms and Implications of Metabolic Heterogeneity in Cancer

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Tumors display reprogrammed metabolic activities that promote cancer progression. We currently possess a limited understanding of the processes governing tumor metabolism in vivo and of the most efficient approaches to identify metabolic vulnerabilities susceptible to therapeutic targeting. While much of the literature focuses on stereotyped, cell-autonomous pathways like glycolysis, recent work emphasizes heterogeneity and flexibility of metabolism between tumors and even within distinct regions of solid tumors. Metabolic heterogeneity is important because it influences therapeutic vulnerabilities and may predict clinical outcomes. This Review describes current concepts about metabolic regulation in tumors, focusing on processes intrinsic to cancer cells and on factors imposed upon cancer cells by the tumor microenvironment. We discuss experimental approaches to identify subtype-selective metabolic vulnerabilities in preclinical cancer models. Finally, we describe efforts to characterize metabolism in primary human tumors, which should produce new insights into metabolic heterogeneity in the context of clinically relevant microenvironments. Tumors display substantial metabolic heterogeneity and flexibility. This review discusses convergent and divergent metabolic properties in tumors, and how factors intrinsic and extrinsic to malignant cells establish metabolic phenotypes in the tumor microenvironment. Understanding these concepts will help us develop strategies to capitalize on metabolic reprogramming in cancer treatment.

Original languageEnglish (US)
Pages (from-to)434-446
Number of pages13
JournalCell Metabolism
Volume30
Issue number3
DOIs
StatePublished - Sep 3 2019

Fingerprint

Neoplasms
Tumor Microenvironment
Cellular Microenvironment
Intrinsic Factor
Glycolysis
Phenotype
Therapeutics

ASJC Scopus subject areas

  • Physiology
  • Molecular Biology
  • Cell Biology

Cite this

Mechanisms and Implications of Metabolic Heterogeneity in Cancer. / Kim, Jiyeon; DeBerardinis, Ralph J.

In: Cell Metabolism, Vol. 30, No. 3, 03.09.2019, p. 434-446.

Research output: Contribution to journalReview article

@article{73e46eaedf6b42c78cd5ca6ce5d0d039,
title = "Mechanisms and Implications of Metabolic Heterogeneity in Cancer",
abstract = "Tumors display reprogrammed metabolic activities that promote cancer progression. We currently possess a limited understanding of the processes governing tumor metabolism in vivo and of the most efficient approaches to identify metabolic vulnerabilities susceptible to therapeutic targeting. While much of the literature focuses on stereotyped, cell-autonomous pathways like glycolysis, recent work emphasizes heterogeneity and flexibility of metabolism between tumors and even within distinct regions of solid tumors. Metabolic heterogeneity is important because it influences therapeutic vulnerabilities and may predict clinical outcomes. This Review describes current concepts about metabolic regulation in tumors, focusing on processes intrinsic to cancer cells and on factors imposed upon cancer cells by the tumor microenvironment. We discuss experimental approaches to identify subtype-selective metabolic vulnerabilities in preclinical cancer models. Finally, we describe efforts to characterize metabolism in primary human tumors, which should produce new insights into metabolic heterogeneity in the context of clinically relevant microenvironments. Tumors display substantial metabolic heterogeneity and flexibility. This review discusses convergent and divergent metabolic properties in tumors, and how factors intrinsic and extrinsic to malignant cells establish metabolic phenotypes in the tumor microenvironment. Understanding these concepts will help us develop strategies to capitalize on metabolic reprogramming in cancer treatment.",
author = "Jiyeon Kim and DeBerardinis, {Ralph J}",
year = "2019",
month = "9",
day = "3",
doi = "10.1016/j.cmet.2019.08.013",
language = "English (US)",
volume = "30",
pages = "434--446",
journal = "Cell Metabolism",
issn = "1550-4131",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - Mechanisms and Implications of Metabolic Heterogeneity in Cancer

AU - Kim, Jiyeon

AU - DeBerardinis, Ralph J

PY - 2019/9/3

Y1 - 2019/9/3

N2 - Tumors display reprogrammed metabolic activities that promote cancer progression. We currently possess a limited understanding of the processes governing tumor metabolism in vivo and of the most efficient approaches to identify metabolic vulnerabilities susceptible to therapeutic targeting. While much of the literature focuses on stereotyped, cell-autonomous pathways like glycolysis, recent work emphasizes heterogeneity and flexibility of metabolism between tumors and even within distinct regions of solid tumors. Metabolic heterogeneity is important because it influences therapeutic vulnerabilities and may predict clinical outcomes. This Review describes current concepts about metabolic regulation in tumors, focusing on processes intrinsic to cancer cells and on factors imposed upon cancer cells by the tumor microenvironment. We discuss experimental approaches to identify subtype-selective metabolic vulnerabilities in preclinical cancer models. Finally, we describe efforts to characterize metabolism in primary human tumors, which should produce new insights into metabolic heterogeneity in the context of clinically relevant microenvironments. Tumors display substantial metabolic heterogeneity and flexibility. This review discusses convergent and divergent metabolic properties in tumors, and how factors intrinsic and extrinsic to malignant cells establish metabolic phenotypes in the tumor microenvironment. Understanding these concepts will help us develop strategies to capitalize on metabolic reprogramming in cancer treatment.

AB - Tumors display reprogrammed metabolic activities that promote cancer progression. We currently possess a limited understanding of the processes governing tumor metabolism in vivo and of the most efficient approaches to identify metabolic vulnerabilities susceptible to therapeutic targeting. While much of the literature focuses on stereotyped, cell-autonomous pathways like glycolysis, recent work emphasizes heterogeneity and flexibility of metabolism between tumors and even within distinct regions of solid tumors. Metabolic heterogeneity is important because it influences therapeutic vulnerabilities and may predict clinical outcomes. This Review describes current concepts about metabolic regulation in tumors, focusing on processes intrinsic to cancer cells and on factors imposed upon cancer cells by the tumor microenvironment. We discuss experimental approaches to identify subtype-selective metabolic vulnerabilities in preclinical cancer models. Finally, we describe efforts to characterize metabolism in primary human tumors, which should produce new insights into metabolic heterogeneity in the context of clinically relevant microenvironments. Tumors display substantial metabolic heterogeneity and flexibility. This review discusses convergent and divergent metabolic properties in tumors, and how factors intrinsic and extrinsic to malignant cells establish metabolic phenotypes in the tumor microenvironment. Understanding these concepts will help us develop strategies to capitalize on metabolic reprogramming in cancer treatment.

UR - http://www.scopus.com/inward/record.url?scp=85070895202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070895202&partnerID=8YFLogxK

U2 - 10.1016/j.cmet.2019.08.013

DO - 10.1016/j.cmet.2019.08.013

M3 - Review article

C2 - 31484055

AN - SCOPUS:85070895202

VL - 30

SP - 434

EP - 446

JO - Cell Metabolism

JF - Cell Metabolism

SN - 1550-4131

IS - 3

ER -